Covaxin, one of the COVID-19 drugs in India, does not have the World Health Organisation’s (WHO) approval for now. Thus, those vaccinated against COVID-19 by Covaxin might not be allowed to travel internationally till the time it gets approved; it is only approved by nine countries for now.
Most of the countries will be following WHO’s list while opening their borders, the list that does not include Covaxin yet. This is leading fear among the students as academic sessions are set to begin by August-September in foreign universities.
However, Bharat biotech is confident of getting WHO’s approval for Covaxin.
Bharat Biotech conducted a meeting on May 25 with the government regarding the matter as the proposal regarding Covaxin has already been sent to WHO.
The WHO has Pfizer, Moderna and Covishield on its approved list but for Covaxin, it says “more information required”.
The company during the meeting mentioned that they have submitted “90 per cent of the documentation required” to WHO. “The remaining is expected to be submitted in June,” the company added.
Bharat Biotech is positive about of getting clearance subsequently, “given its experience of getting its other vaccines pre-qualified by WHO”. The company was among the few companies that had published papers on all four Covid virus variants, according to sources.
Covaxin has received regulatory approvals from 11 countries, it was pointed out, and 11 companies in seven countries have shown interest towards the technology transfer and production of the Covid shot.
“It is important to note that no country has instituted a vaccine passport. Countries have their own requirements for approval, which in most cases involves travel by carrying a negative RT-PCR report,” Bharat Biotech reportedly said.